CDSCO Panel Tells Synokem to conduct phase 3 CT of antidiabetic FDC drug Dr. Divya Colin5 Feb 2023 12:30 PMNew Delhi: Highlighting that there is no sufficient data, no unmet need & and FDC is not approved the drug internationally, the Subject Expert...
Alkem Gets CDSCO panel nod to manufacture, market antidiabetic FDC Drug Dr. Divya Colin1 Feb 2023 12:30 PMNew Delhi: The drug major, Alkem Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
NPPA Fixes Retail Price Of 12 Formulations, Details Dr. Divya Colin14 Jan 2023 10:30 AMNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government of...
Metformin or lifestyle changes initiated for diabetes prevention may not reduce risk of AMD: JAMA Dr Ishan Kataria13 Jan 2023 4:30 AMAge-related macular degeneration (AMD) is one of the most prevalent age-related eye conditions and a leading cause of blindness in the US. Early and...
Renoprotective effect of Metformin independent of blood sugar control in patients with diabetic kidney disease Dr Kartikeya Kohli12 Jan 2023 5:15 AMChina: A recent study published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy revealed that metformin's renoprotective effect is...
NPPA Fixes Retail Price Of 36 Formulations, Details Dr. Divya Colin11 Jan 2023 12:30 PMNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, the Government of...
Maternal use of Metformin for gestational diabetes not tied to adverse neonatal outcomes Dr Kartikeya Kohli11 Jan 2023 5:15 AMChina: Metformin, when used for treating gestational diabetes, has some benefits over insulin and is a safe oral antihyperglycemic drug without an...
Metformin therapy significantly lowers incidence of long Covid Jacinthlyn Sylvia30 Dec 2022 5:15 AMA randomized phase 3 study from the Cold Spring Harbor Laboratory found that the incidence of Long Covid was 42% lower in the metformin group...
What ADA/EASD consensus guideline has to say about metformin for hyperglycemia management in type 2 diabetes Medha Baranwal28 Dec 2022 2:30 PMUSA: Metformin has high effectiveness in lowering HbA1c, minimal risk of hypoglycemia when used as monotherapy, good safety profile, low cost, and...
Metformin, promising adjuvant therapy for breast cancer treatment in obese postmenopausal women Dr Kartikeya Kohli27 Dec 2022 5:30 AMEgypt: Metformin could be a safe and promising adjuvant therapy to letrozole in overweight/obese postmenopausal women with breast cancer, a recent...
Metformin and insulin improve risk factors of cardiovascular and cerebrovascular disease in type 1 diabetes Medha Baranwal23 Dec 2022 2:30 PMChina: In people with type 1 diabetes, metformin can improve cerebrovascular and cardiovascular risk factors through non-hypoglycemic multiple...
Glenmark Pharma unveils triple FDC Zita-PioMet for Type 2 diabetes in India Ruchika Sharma23 Dec 2022 5:45 AMThis offers patients with Type 2 diabetes the convenience of once-daily dosing to improve their glycemic control and achieve the targeted HbA1c within...
